You just read:

Takeda Completes Settlements With All Defendants in U.S. Patent Litigation Involving ACTOS® (pioglitazone HCI), ACTOplus met® (pioglitazone HCl and metformin HCl) and duetact® (pioglitazone HCl and glimepiride)

News provided by

Takeda Pharmaceuticals North America, Inc.

Dec 21, 2010, 06:30 EST